MannKind (Clinical Program Rights) Overview

  • Status

  • Acquired/​Merged

  • Latest Deal Type

  • Asset Purch.

  • Financing Rounds

  • 1

MannKind (Clinical Program Rights) General Information

Description

A right for the development of pharmaceutical products. The asset comprises of worldwide rights to the immuno-therapeutic cancer, allergy and infectious disease clinical programs of MannKind.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Colby Pharmaceutical
Primary Office
  • 25134 Rye Canyon Loop
  • Suite 300
  • Valencia, CA 91355
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MannKind (Clinical Program Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MannKind (Clinical Program Rights)‘s full profile, request access.

Request a free trial

MannKind (Clinical Program Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MannKind (Clinical Program Rights)‘s full profile, request access.

Request a free trial